๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Nonalcoholic fatty liver disease: Diagnosis and relation to metabolic syndrome and approach to treatment

โœ Scribed by Steven D. Lidofsky

Book ID
107536386
Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
209 KB
Volume
8
Category
Article
ISSN
1534-4827

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Need for a three-focused approach to non
Need for a three-focused approach to nonalcoholic fatty liver disease
โœ Giovanni Musso; Roberto Gambino; Maurizio Cassader ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 296 KB

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

Adipocyte fatty acid binding protein lev
Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease
โœ Kerry-Lee Milner; David van der Poorten; Aimin Xu; Elisabetta Bugianesi; James G ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 229 KB ๐Ÿ‘ 2 views

Several circulating cytokines are increased with obesity and may combine with the influence of visceral fat to generate insulin resistance, inflammation, and fibrosis in nonalcoholic fatty liver disease (NAFLD). Little information exists in NAFLD about three recently recognized tissue-derived cytoki

Metabolic syndrome in liver transplantat
Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression
โœ Giampaolo Bianchi; Giulio Marchesini; Rebecca Marzocchi; Antonio D. Pinna; Marco ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

Excessive weight gain, hypertension, hyperlipidemia, and diabetes are frequently observed in patients having undergone liver transplantation (LTx). These alterations are probably multifactorial in origin, and cluster to generate a metabolic syndrome (MS), increasing the risk of cardiovascular events